Sort
30,917 grants matching “tumor microenvironment”
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$540,450Gordon B. Mills · Oregon Health & Science University · U01 · FY2021 · CA
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$540,401John K. Wiencke · University Of California, San Francisco · P50 · FY2020 · CA
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$540,369Lishan Su · University Of Maryland Baltimore · R01 · FY2020 · AI
Hyperplexed Quantum Dots for Multidimensional Cell Classification in Intact Tissue
$540,320Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2024 · EB
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$540,293Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2024 · CA
Structure-informed dissection of cancer-specific intracellular and paracrine networks
$540,241Barry H Honig · Columbia University Health Sciences · U54 · FY2024 · CA
Predicting Prostate Cancer Aggressiveness
$540,144Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2014 · CA
KSHV,HIV and the Kaposi's Sarcoma Tumor Niche
$540,119John T. West · Lsu Health Sciences Center · R01 · FY2022 · CA
Developing new therapeutic strategies for brain metastasis
$540,115Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
NASH-associated macrophages: regulation and role in disease pathogenesis
$540,053Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Delineating Functional Immunity via Image-Guided PET
$539,930Nerissa Therese Viola · Wayne State University · R37 · FY2021 · CA
Small molecule CXCR4 modulators as molecular probes for studying AML
$539,886Gary E Schiltz · Northwestern University · R01 · FY2016 · CA
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
$539,860Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Heparan Sulfate in Prostate Cancer
$539,856Lianchun Wang · University Of South Florida · U01 · FY2020 · CA
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
$539,855Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
$539,600Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2025 · CA
Center for Modeling Tumor Cell Migration Mechanics: Administrative Core
$539,596David J Odde · University Of Minnesota · U54 · FY2020 · CA
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
$539,533Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Novel strategies to improve mesothelioma therapy
$539,493Haining Yang · University Of Hawaii At Manoa · R01 · FY2024 · CA
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$539,448Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2025 · CA
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
$539,426Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$539,424Albert Folch · University Of Washington · R01 · FY2025 · CA
The Role of GABA Transaminase ABAT in Pediatric Brain Tumor Medulloblastoma Development and Spread
$539,414Josh Neman-Ebrahim · University Of Southern California · R01 · FY2024 · NS
Preclinical Electron Paramagnetic Resonance Tumor Imager
$539,291Gareth R Eaton · University Of Denver (Colorado Seminary) · R01 · FY2021 · CA
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
$539,269Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA